188 related articles for article (PubMed ID: 28615991)
41. [Relation of MiR-34a Expression in Diffuse Large B Cell Lymphoma with Clinical Prognosis].
Liu YP; Hu H; Xu F; Wen JJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):455-459. PubMed ID: 28446292
[TBL] [Abstract][Full Text] [Related]
42. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
[TBL] [Abstract][Full Text] [Related]
43. Inhibitory effect of microRNA-34a on retinal pigment epithelial cell proliferation and migration.
Hou Q; Tang J; Wang Z; Wang C; Chen X; Hou L; Dong XD; Tu L
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6481-8. PubMed ID: 23970470
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44.
Yu G; Yao W; Xiao W; Li H; Xu H; Lang B
J Exp Clin Cancer Res; 2014 Dec; 33(1):779. PubMed ID: 25551284
[TBL] [Abstract][Full Text] [Related]
45. Dual biomarkers long non-coding RNA GAS5 and microRNA-34a co-expression signature in common solid tumors.
Toraih EA; Alghamdi SA; El-Wazir A; Hosny MM; Hussein MH; Khashana MS; Fawzy MS
PLoS One; 2018; 13(10):e0198231. PubMed ID: 30289954
[TBL] [Abstract][Full Text] [Related]
46. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
47. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
Huang Y; Zou Y; Lin L; Ma X; Chen H
Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
Pang RT; Leung CO; Ye TM; Liu W; Chiu PC; Lam KK; Lee KF; Yeung WS
Carcinogenesis; 2010 Jun; 31(6):1037-44. PubMed ID: 20351093
[TBL] [Abstract][Full Text] [Related]
49. Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway.
Luo Y; Ouyang J; Zhou D; Zhong S; Wen M; Ou W; Yu H; Jia L; Huang Y
Dig Dis Sci; 2018 Apr; 63(4):890-899. PubMed ID: 29427222
[TBL] [Abstract][Full Text] [Related]
50. Alcohol-mediated miR-34a modulates hepatocyte growth and apoptosis.
Iwagami Y; Zou J; Zhang H; Cao K; Ji C; Kim M; Huang CK
J Cell Mol Med; 2018 Aug; 22(8):3987-3995. PubMed ID: 29873178
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-34a functions as a tumor suppressor by directly targeting oncogenic PLCE1 in Kazakh esophageal squamous cell carcinoma.
Cui XB; Peng H; Li RR; Mu JQ; Yang L; Li N; Liu CX; Hu JM; Li SG; Wei Y; Laibo-Yin ; Zhou H; Li F; Chen YZ
Oncotarget; 2017 Nov; 8(54):92454-92469. PubMed ID: 29190930
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer.
Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY
Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749
[TBL] [Abstract][Full Text] [Related]
53. The molecular mechanism of LncRNA34a-mediated regulation of bone metastasis in hepatocellular carcinoma.
Zhang L; Niu H; Ma J; Yuan BY; Chen YH; Zhuang Y; Chen GW; Zeng ZC; Xiang ZL
Mol Cancer; 2019 Jul; 18(1):120. PubMed ID: 31349837
[TBL] [Abstract][Full Text] [Related]
54. Expression and role of miR-34a in bladder cancer.
Wang W; Li T; Han G; Li Y; Shi LH; Li H
Indian J Biochem Biophys; 2013 Apr; 50(2):87-92. PubMed ID: 23720881
[TBL] [Abstract][Full Text] [Related]
55. Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
Wang Y; Jia LS; Yuan W; Wu Z; Wang HB; Xu T; Sun JC; Cheng KF; Shi JG
Am J Transl Res; 2015; 7(1):111-9. PubMed ID: 25755833
[TBL] [Abstract][Full Text] [Related]
56. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
57. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-138 inhibits proliferation of cervical cancer cells by targeting c-Met.
Li B; Yang XX; Wang D; Ji HK
Eur Rev Med Pharmacol Sci; 2016; 20(6):1109-14. PubMed ID: 27049264
[TBL] [Abstract][Full Text] [Related]
59. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
Liu W; Zhao ZY; Shi L; Yuan WD
Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
[TBL] [Abstract][Full Text] [Related]
60. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
